Status:
COMPLETED
Effect of Ketorolac on Post Adenotonsillectomy Pain
Lead Sponsor:
Emory University
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
2-18 years
Phase:
PHASE4
Brief Summary
This randomized prospective study aims to determine the effect of ketorolac on the total dose of morphine required to achieve postoperative analgesia in children with obstructive sleep apnea (OSA) und...
Detailed Description
Obstructive sleep apnea (OSA) as an indication for adenotonsillectomy has increased significantly over the past ten years, and now has surpassed recurrent tonsillitis as the most common indication for...
Eligibility Criteria
Inclusion
- Diagnosis of sleep disordered breathing or obstructive sleep apnea
- Children undergoing elective tonsillectomy or adenotonsillectomy at Children's Healthcare of Atlanta Egleston location
- Parent or legal guardian willing to participate, and able to understand and sign the provided informed consent
Exclusion
- Known coagulation defect
- Patients on longstanding NSAID therapy
- Known renal impairment
Key Trial Info
Start Date :
July 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03467750
Start Date
July 19 2018
End Date
August 22 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Healthcare of Atlanta, Egleston
Atlanta, Georgia, United States, 30322